Boris Lubicz1, Alexandre Kadou2, Ricardo Morais2, Benjamin Mine2. 1. Department of Interventional Neuroradiology, Erasme University Hospital, 808 route de Lennik, 1070, Bruxelles, Belgium. blubicz@ulb.ac.be. 2. Department of Interventional Neuroradiology, Erasme University Hospital, 808 route de Lennik, 1070, Bruxelles, Belgium.
Abstract
INTRODUCTION: The Leo stent was the first retrievable stent for endovascular treatment of intracranial aneurysms (IAs). We report our experience with this device with emphasis on very long-term follow-up. METHODS: This study was approved by authors' ethical committee. A retrospective review of our prospectively maintained database identified all patients treated for a saccular IA with this stent in our institution. Technical issues and immediate and long-term outcomes (at least 12 months) were evaluated. RESULTS: Between 2004 and 2015, 50 patients with 52 IAs were identified. In two patients, the stent could not safely be placed (failure rate = 3.8%). Among 48 treated patients with 50 IAs, there were 44 women and 4 men (mean age, 53 years). Mean aneurysm diameter was 7.2 mm. All IAs but six were wide-necked. There was no immediate morbidity or mortality. Anatomical results included 76% complete occlusions, 22% neck remnants, and 2% incomplete occlusions. Mean follow-up was 50.2 months (range, 12-139 months). Two patients had delayed TIAs but long-term morbidity rate remained = 0%. At follow-up, occlusion was stable in 68% IAs, showed thrombosis in 12%, and recanalization in 20% IAs. Complementary treatment was required in 8% IAs. Final results showed 70% complete occlusions, 24% neck remnants, and 6% incomplete occlusions. Asymptomatic stent occlusion and significant stenosis occurred in one and two cases, respectively. CONCLUSION: The Leo stent is safe and effective for treatment of wide-necked saccular IAs. Very long-term results show high rates of adequate and stable occlusion. Moreover, the stent is well tolerated.
INTRODUCTION: The Leo stent was the first retrievable stent for endovascular treatment of intracranial aneurysms (IAs). We report our experience with this device with emphasis on very long-term follow-up. METHODS: This study was approved by authors' ethical committee. A retrospective review of our prospectively maintained database identified all patients treated for a saccular IA with this stent in our institution. Technical issues and immediate and long-term outcomes (at least 12 months) were evaluated. RESULTS: Between 2004 and 2015, 50 patients with 52 IAs were identified. In two patients, the stent could not safely be placed (failure rate = 3.8%). Among 48 treated patients with 50 IAs, there were 44 women and 4 men (mean age, 53 years). Mean aneurysm diameter was 7.2 mm. All IAs but six were wide-necked. There was no immediate morbidity or mortality. Anatomical results included 76% complete occlusions, 22% neck remnants, and 2% incomplete occlusions. Mean follow-up was 50.2 months (range, 12-139 months). Two patients had delayed TIAs but long-term morbidity rate remained = 0%. At follow-up, occlusion was stable in 68% IAs, showed thrombosis in 12%, and recanalization in 20% IAs. Complementary treatment was required in 8% IAs. Final results showed 70% complete occlusions, 24% neck remnants, and 6% incomplete occlusions. Asymptomatic stent occlusion and significant stenosis occurred in one and two cases, respectively. CONCLUSION: The Leo stent is safe and effective for treatment of wide-necked saccular IAs. Very long-term results show high rates of adequate and stable occlusion. Moreover, the stent is well tolerated.
Authors: P Machi; V Costalat; K Lobotesis; C Ruiz; Y B Cheikh; O Eker; G Gascou; F Danière; C Riquelme; A Bonafé Journal: AJNR Am J Neuroradiol Date: 2015-08-13 Impact factor: 3.825
Authors: I Akmangit; K Aydin; S Sencer; O M Topcuoglu; E D Topcuoglu; E Daglioglu; M Barburoglu; A Arat Journal: AJNR Am J Neuroradiol Date: 2014-09-18 Impact factor: 3.825
Authors: José Manuel Pumar; Susana Arias-Rivas; Manuel Rodríguez-Yáñez; Miguel Blanco; Maria Ageitos; Fernando Vazquez-Herrero; José Antonio Castiñeira-Mourenza; Amaya Masso Journal: J Neurointerv Surg Date: 2013-04-12 Impact factor: 5.836
Authors: L Pierot; J Klisch; T Liebig; J-Y Gauvrit; M Leonardi; N P Nuzzi; F Di Paola; V Sychra; B Mine; B Lubicz Journal: AJNR Am J Neuroradiol Date: 2015-07-30 Impact factor: 3.825
Authors: Catherine Strittmatter; Lukas Meyer; Gabriel Broocks; Maria Alexandrou; Maria Politi; Maria Boutchakova; Andreas Henssler; Marcus Reinges; Andreas Simgen; Panagiotis Papanagiotou; Christian Roth Journal: J Clin Med Date: 2022-06-16 Impact factor: 4.964